NCT06833216View on ClinicalTrials.gov

Familial Breast Cancer in China

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

February 28, 2025

Study Completion Date

February 28, 2035

Conditions
Breast CarcinomaGenetic Variation
Interventions
OTHER

Genetic variation

To observe and describe the clinical features, diagnosis and treatment plan and survival prognosis of familial hereditary breast cancer in China, and explore the main factors affecting prognosis.

Trial Locations (1)

100021

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing

All Listed Sponsors
lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER

NCT06833216 - Familial Breast Cancer in China | Biotech Hunter | Biotech Hunter